Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2013-04-04 | Philip H. Moise is nominated for election to the Board for a three year term ending at the 2016 Annual Meeting of Shareholders to fill the position held by Dr. John Peatman who is retiring at the end of his term in May 2013. Mr. Moise served as Executive Vice President, General Counsel and Secretary of Immucor, Inc. from 2007 until 2012. Immucor manufactures and sells instruments and reagents used to classify components of human blood prior to blood therapies and transfusions. |
| 2014-04-04 | Mr. Moise served as Executive Vice President, General Counsel and Secretary of Immucor, Inc. |
| 2015-04-13 | Philip H. Moise, Director, Former Executive Vice President and General Counsel of Immucor, Inc. |
| 2016-04-01 | Mr. Moise served as Executive Vice President, General Counsel and Secretary of Immucor, Inc. from 2007 until 2012. Immucor manufactures and sells instruments and reagents used to classify components of human blood prior to blood therapies and transfusions. |
| 2017-04-05 | Mr. Moise served as Executive Vice President, General Counsel and Secretary of Immucor, Inc. |
| 2018-04-02 | Mr. Moise served as Executive Vice President, General Counsel and Secretary of Immucor, Inc. from 2007 until 2012. |
| 2019-04-12 | Mr. Moise served as Executive Vice President, General Counsel and Secretary of Immucor, Inc. from 2007 until 2012. |
| 2020-07-13 | Philip H. Moise has served as a director since 2013. |
| 2021-04-09 | Philip H. Moise, Director, Retired Executive Vice President and General Counsel of Immucor, Inc. |
| 2022-04-08 | Mr. Moise served as Executive Vice President, General Counsel and Secretary of Immucor, Inc. from 2007 until 2012. Immucor manufactures and sells instruments and reagents used to classify components of human blood prior to blood therapies and transfusions. |
| 2023-04-14 | Mr. Moise was in the private practice of law for almost 30 years, where he represented public and private companies in the technology and life sciences industries. |
| 2024-04-12 | Director, Retired Executive Vice President and General Counsel of Immucor, Inc. |
Data sourced from SEC filings. Last updated: 2025-07-01